Francis Collins Advocates for Vaccine Acceptance Among Religious Communities
In a recent interview on the “First Opinion Podcast,” renowned geneticist Francis Collins emphasized the…
Newswire
Nine More MFN Deals Highlight Shift in Pharma Landscape
In a significant development, nine new Most Favored Nation (MFN) deals have been announced, underscoring…
FDA Approves Jascayd for Progressive Pulmonary Fibrosis Treatment
The U.S. Food and Drug Administration (FDA) has granted approval for Jascayd (nerandomilast) tablets, marking…
FDA Approves Cytokinetics’ Heart Drug, Giving It an Edge Over BMS Rival
Cytokinetics has achieved a significant milestone with the recent FDA approval of its heart drug,…
JAX and NYSCF Launch Unified Organization to Accelerate Biomedical Research
The Jackson Laboratory (JAX) and the New York Stem Cell Foundation (NYSCF) have officially launched…
Cytokinetics Secures First FDA Approval for Heart Drug Myqorzo
It took 27 years, but Cytokinetics has achieved a significant milestone by securing its first…
Kennedy Vaccine Adviser William Thompson Promoted to Oversee CDC’s Childhood Health Research
WASHINGTON — William Thompson, a vaccine adviser at the Centers for Disease Control and Prevention…
Galux and Boehringer Ingelheim Agree to Design Purpose-Specific Protein Molecules
Galux, a South Korean biotech specializing in AI-driven protein therapeutics discovery, has entered into a…
Patient deaths put Merck, Daiichi’s ADC trial on partial hold
The FDA has imposed a partial hold on the clinical trial of I-DXd, a novel…
UnitedHealth Claims Robust Audit Findings Amid Contradictory Independent Reviews
UnitedHealth Group announced on Friday that its recent audits, conducted by hired consultants, reveal that…